Clinical Trial Update: An Extension Study to Assess the Long-term Safety and Efficacy of Hunterase (Idursulfase Beta) [Phase 3]

View source ↗

Summary

An extension Phase 3 trial update to assess the long-term safety and efficacy of Hunterase (Idursulfase Beta) in Mucopolysaccharidosis type II/Hunter syndrome. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hunter Syndrome
• Mucopolysaccharidosis Type Ii

Drugs mentioned

• Hunterase (Idursulfase Beta)

Snippet

Sponsor: GC Biopharma Corp | Conditions: MPS II, Hunter Syndrome (MPS II) | Phase 3 | Status: COMPLETED